http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2622745-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80aac14233070bd0cc7b3516bf51fbcc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-02 |
| filingDate | 2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d743c3f950387574378bef61f00e221f |
| publicationDate | 2017-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2622745-C2 |
| titleOfInvention | Based on bioresources compositions for prevention or treatment of sepsis and/or sepsis-related complications and conditions, methods for sepsis prevention and treatment |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to the field of medicine and deals with application of composition, containing hydrolysate, obtained by means of acidic and/or fermentative hydrolysis of one or more bioresources, selected from the group including bivalve molluscs, annelids, leeches; and water, for prevention or treatment of sepsis and/or sepsis-related complications and conditions in mammal requiring such treatment or prevention. Essence of the method consists in the following: composition, containing hydrolysate, obtained by means of acidic and/or fermentative hydrolysis of one or more bioresources, selected from the group including bivalve molluscs, annelids, leeches; and water is parenterally introduced to patient for 1-10 days in dose 10-400 mcl/h. n EFFECT: application of the invention makes it possible to increase efficiency of sepsis treatment. n 30 cl, 7 tbl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021206589-A1 |
| priorityDate | 2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.